| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | 1.45e-03 | 749 | 14 | 4 | GO:0005509 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 3.02e-03 | 430 | 14 | 3 | GO:0004175 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 3.11e-03 | 120 | 14 | 2 | GO:0004222 | |
| GeneOntologyMolecularFunction | integrin binding | 6.48e-03 | 175 | 14 | 2 | GO:0005178 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 8.39e-03 | 200 | 14 | 2 | GO:0008237 | |
| GeneOntologyMolecularFunction | peptidase activity | 9.72e-03 | 654 | 14 | 3 | GO:0008233 | |
| GeneOntologyBiologicalProcess | positive regulation of osteoblast proliferation | 5.15e-05 | 15 | 15 | 2 | GO:0033690 | |
| GeneOntologyBiologicalProcess | serotonin transport | 2.42e-04 | 32 | 15 | 2 | GO:0006837 | |
| GeneOntologyBiologicalProcess | regulation of osteoblast proliferation | 2.73e-04 | 34 | 15 | 2 | GO:0033688 | |
| GeneOntologyBiologicalProcess | osteoblast proliferation | 3.98e-04 | 41 | 15 | 2 | GO:0033687 | |
| GeneOntologyCellularComponent | ruffle membrane | 2.66e-03 | 108 | 15 | 2 | GO:0032587 | |
| GeneOntologyCellularComponent | filopodium | 3.43e-03 | 123 | 15 | 2 | GO:0030175 | |
| MousePheno | abnormal susceptibility to induced thrombosis | 1.43e-05 | 53 | 13 | 3 | MP:0020408 | |
| MousePheno | abnormal thrombosis | 1.15e-04 | 106 | 13 | 3 | MP:0005048 | |
| MousePheno | abnormal tumor morphology | 1.74e-04 | 122 | 13 | 3 | MP:0003448 | |
| MousePheno | increased susceptibility to induced thrombosis | 2.18e-04 | 24 | 13 | 2 | MP:0031121 | |
| MousePheno | abnormal tumor pathology | 5.11e-04 | 176 | 13 | 3 | MP:0010639 | |
| MousePheno | increased tumor growth/size | 8.79e-04 | 48 | 13 | 2 | MP:0003721 | |
| MousePheno | abnormal blood coagulation | 1.26e-03 | 240 | 13 | 3 | MP:0002551 | |
| MousePheno | abnormal hemostasis | 1.29e-03 | 242 | 13 | 3 | MP:0009676 | |
| MousePheno | abnormal motor learning | 1.37e-03 | 60 | 13 | 2 | MP:0002804 | |
| Domain | EGF_1 | 2.58e-10 | 255 | 14 | 7 | PS00022 | |
| Domain | EGF_2 | 3.37e-10 | 265 | 14 | 7 | PS01186 | |
| Domain | EGF | 1.03e-08 | 235 | 14 | 6 | SM00181 | |
| Domain | EGF_3 | 1.03e-08 | 235 | 14 | 6 | PS50026 | |
| Domain | EGF-like_dom | 1.45e-08 | 249 | 14 | 6 | IPR000742 | |
| Domain | EGF-like_CS | 1.92e-08 | 261 | 14 | 6 | IPR013032 | |
| Domain | ASX_HYDROXYL | 7.43e-07 | 100 | 14 | 4 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.39e-07 | 106 | 14 | 4 | IPR000152 | |
| Domain | EGF_CA | 1.65e-06 | 122 | 14 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.76e-06 | 124 | 14 | 4 | IPR001881 | |
| Domain | EGF | 1.88e-06 | 126 | 14 | 4 | PF00008 | |
| Domain | GPS | 1.98e-06 | 34 | 14 | 3 | SM00303 | |
| Domain | GPS | 2.16e-06 | 35 | 14 | 3 | PF01825 | |
| Domain | GPS | 2.36e-06 | 36 | 14 | 3 | PS50221 | |
| Domain | GPS | 2.57e-06 | 37 | 14 | 3 | IPR000203 | |
| Domain | LAM_G_DOMAIN | 2.78e-06 | 38 | 14 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 3.26e-06 | 40 | 14 | 3 | PF02210 | |
| Domain | LamG | 4.36e-06 | 44 | 14 | 3 | SM00282 | |
| Domain | 7tm_2 | 6.44e-06 | 50 | 14 | 3 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 6.44e-06 | 50 | 14 | 3 | PS00650 | |
| Domain | Laminin_G | 1.01e-05 | 58 | 14 | 3 | IPR001791 | |
| Domain | GPCR_2-like | 1.12e-05 | 60 | 14 | 3 | IPR017981 | |
| Domain | GPCR_2_secretin-like | 1.12e-05 | 60 | 14 | 3 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.18e-05 | 61 | 14 | 3 | PS50261 | |
| Domain | GAIN_dom_N | 2.86e-05 | 11 | 14 | 2 | IPR032471 | |
| Domain | GAIN | 2.86e-05 | 11 | 14 | 2 | PF16489 | |
| Domain | FA58C | 1.09e-04 | 21 | 14 | 2 | SM00231 | |
| Domain | FA58C_3 | 1.09e-04 | 21 | 14 | 2 | PS50022 | |
| Domain | FA58C_1 | 1.09e-04 | 21 | 14 | 2 | PS01285 | |
| Domain | FA58C_2 | 1.09e-04 | 21 | 14 | 2 | PS01286 | |
| Domain | F5_F8_type_C | 1.43e-04 | 24 | 14 | 2 | PF00754 | |
| Domain | FA58C | 1.43e-04 | 24 | 14 | 2 | IPR000421 | |
| Domain | HormR | 1.55e-04 | 25 | 14 | 2 | SM00008 | |
| Domain | Growth_fac_rcpt_ | 1.94e-04 | 156 | 14 | 3 | IPR009030 | |
| Domain | HRM | 1.95e-04 | 28 | 14 | 2 | PF02793 | |
| Domain | FIBRINOGEN_C_2 | 2.55e-04 | 32 | 14 | 2 | PS51406 | |
| Domain | Fibrinogen_a/b/g_C_dom | 2.55e-04 | 32 | 14 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_1 | 2.55e-04 | 32 | 14 | 2 | PS00514 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 4.00e-04 | 40 | 14 | 2 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 4.00e-04 | 40 | 14 | 2 | PS50227 | |
| Domain | GPCR_2_extracellular_dom | 4.00e-04 | 40 | 14 | 2 | IPR001879 | |
| Domain | ConA-like_dom | 5.26e-04 | 219 | 14 | 3 | IPR013320 | |
| Domain | TSP_1 | 9.93e-04 | 63 | 14 | 2 | PF00090 | |
| Domain | TSP1_rpt | 1.06e-03 | 65 | 14 | 2 | IPR000884 | |
| Domain | TSP1 | 1.06e-03 | 65 | 14 | 2 | PS50092 | |
| Domain | TSP1 | 1.06e-03 | 65 | 14 | 2 | SM00209 | |
| Domain | EGF_CA | 1.84e-03 | 86 | 14 | 2 | PF07645 | |
| Domain | Galactose-bd-like | 2.19e-03 | 94 | 14 | 2 | IPR008979 | |
| Domain | - | 2.24e-03 | 95 | 14 | 2 | 2.60.120.200 | |
| Domain | EGF_Ca-bd_CS | 2.33e-03 | 97 | 14 | 2 | IPR018097 | |
| Domain | ZINC_PROTEASE | 2.38e-03 | 98 | 14 | 2 | PS00142 | |
| Domain | EGF_CA | 2.43e-03 | 99 | 14 | 2 | PS01187 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.25e-04 | 32 | 12 | 2 | MM14854 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 4.35e-04 | 37 | 12 | 2 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.84e-04 | 39 | 12 | 2 | MM14601 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 6.16e-04 | 44 | 12 | 2 | M26969 | |
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 31150793 | ||
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 26807827 | ||
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 3.51e-07 | 33 | 15 | 3 | 25713288 | |
| Pubmed | Expression of extracellular matrix and adhesion proteins in pelvic organ prolapse. | 5.21e-07 | 3 | 15 | 2 | 29729708 | |
| Pubmed | In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development. | 2.60e-06 | 6 | 15 | 2 | 34143959 | |
| Pubmed | 2.35e-05 | 17 | 15 | 2 | 26389685 | ||
| Pubmed | FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. | 3.99e-05 | 22 | 15 | 2 | 26494785 | |
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 7.00e-05 | 29 | 15 | 2 | 15203201 | |
| Pubmed | Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons. | 7.00e-05 | 29 | 15 | 2 | 31491374 | |
| Pubmed | ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation. | 7.50e-05 | 30 | 15 | 2 | 32882513 | |
| Pubmed | Calsyntenins function as synaptogenic adhesion molecules in concert with neurexins. | 2.27e-04 | 52 | 15 | 2 | 24613359 | |
| Pubmed | 3.45e-04 | 64 | 15 | 2 | 19729601 | ||
| Interaction | RLN1 interactions | 4.16e-05 | 93 | 15 | 3 | int:RLN1 | |
| Interaction | LLCFC1 interactions | 9.11e-05 | 121 | 15 | 3 | int:LLCFC1 | |
| Interaction | CBLN4 interactions | 1.05e-04 | 127 | 15 | 3 | int:CBLN4 | |
| Interaction | ISLR interactions | 1.35e-04 | 138 | 15 | 3 | int:ISLR | |
| Interaction | SLURP1 interactions | 1.53e-04 | 144 | 15 | 3 | int:SLURP1 | |
| Interaction | CDH16 interactions | 1.93e-04 | 28 | 15 | 2 | int:CDH16 | |
| Interaction | LILRA5 interactions | 2.53e-04 | 32 | 15 | 2 | int:LILRA5 | |
| Interaction | DNAJB9 interactions | 4.13e-04 | 202 | 15 | 3 | int:DNAJB9 | |
| Interaction | APOM interactions | 4.59e-04 | 43 | 15 | 2 | int:APOM | |
| Interaction | LY86 interactions | 5.09e-04 | 217 | 15 | 3 | int:LY86 | |
| Interaction | CD160 interactions | 5.72e-04 | 48 | 15 | 2 | int:CD160 | |
| Interaction | CNTNAP3B interactions | 6.20e-04 | 50 | 15 | 2 | int:CNTNAP3B | |
| Interaction | GPR173 interactions | 6.46e-04 | 51 | 15 | 2 | int:GPR173 | |
| Interaction | FOXF2 interactions | 7.24e-04 | 54 | 15 | 2 | int:FOXF2 | |
| Interaction | TRGV3 interactions | 7.51e-04 | 55 | 15 | 2 | int:TRGV3 | |
| Interaction | THY1 interactions | 7.78e-04 | 56 | 15 | 2 | int:THY1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q32 | 1.43e-02 | 566 | 15 | 2 | chr14q32 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.90e-02 | 394 | 10 | 2 | 471 | |
| Coexpression | GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP | 7.01e-05 | 22 | 15 | 2 | M7184 | |
| Coexpression | KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN | 9.10e-05 | 25 | 15 | 2 | M15380 | |
| Coexpression | DESCARTES_ORGANOGENESIS_INHIBITORY_INTERNEURONS | 1.32e-04 | 30 | 15 | 2 | MM3663 | |
| Coexpression | GSE3982_DC_VS_BASOPHIL_DN | 1.83e-04 | 199 | 15 | 3 | M5473 | |
| Coexpression | GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_UP | 1.86e-04 | 200 | 15 | 3 | M7437 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.99e-07 | 176 | 15 | 4 | 72a2a01618ce836bc843395d5095e9090759b4a6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.27e-07 | 180 | 15 | 4 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.34e-07 | 181 | 15 | 4 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.42e-07 | 182 | 15 | 4 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.42e-07 | 182 | 15 | 4 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.98e-07 | 200 | 15 | 4 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 159 | 15 | 3 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 159 | 15 | 3 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.13e-05 | 165 | 15 | 3 | 6799a6580c667738995cceb31cbf1c7fbdc4ff84 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.13e-05 | 165 | 15 | 3 | 8329d780f244bc31344443b29e5a00529a016662 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 170 | 15 | 3 | 8e774af244cfe787fa0ea2b6be0c3c2d00bfe4fc | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 170 | 15 | 3 | f5140eb9313c0d1bb31f8a761d9c062c56733a61 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.46e-05 | 173 | 15 | 3 | 95c723b09254ae7131fe5ba0841472502e83269b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.54e-05 | 175 | 15 | 3 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.59e-05 | 176 | 15 | 3 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | (9)_Platelet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.63e-05 | 177 | 15 | 3 | e63d01c7fce4fa1256212fa7e95f74281edb3a01 | |
| ToppCell | (9)_Platelet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.63e-05 | 177 | 15 | 3 | 0830944c43de300815831a9e2b2fce40965e7d12 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.63e-05 | 177 | 15 | 3 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.63e-05 | 177 | 15 | 3 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-05 | 178 | 15 | 3 | 09475e522dc1b8cf9ff1c25de5d1e3082b162948 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-05 | 178 | 15 | 3 | 35de8f791b0e78a6caf52ff095f05e204a59e828 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.68e-05 | 178 | 15 | 3 | 9fc5688cf705a74398d24e10e0aab4758612e72b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.68e-05 | 178 | 15 | 3 | 431e7557b8e8764e16e9e48368ce6bfa3c61561a | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.68e-05 | 178 | 15 | 3 | 850fcd368c4478c57eaedc74544773ea220f41f3 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-05 | 178 | 15 | 3 | 000d25f3f13cc76cf39c46c312c6fafc2ea4f368 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.68e-05 | 178 | 15 | 3 | a16857da9f2907c176213a326112a1b4cbd0e628 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.72e-05 | 179 | 15 | 3 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.72e-05 | 179 | 15 | 3 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.77e-05 | 180 | 15 | 3 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.81e-05 | 181 | 15 | 3 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.86e-05 | 182 | 15 | 3 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.86e-05 | 182 | 15 | 3 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Megakaryocyte_early|bone_marrow / Manually curated celltypes from each tissue | 2.91e-05 | 183 | 15 | 3 | 3cc9f3dc3bc4bde1d3408b0a6ba58e135a11036d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.91e-05 | 183 | 15 | 3 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.91e-05 | 183 | 15 | 3 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.95e-05 | 184 | 15 | 3 | 23515c28e1f42aab29cef9e5b4a7f45bda7f5520 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega-Megakaryocyte_early|lymph-node_spleen / Manually curated celltypes from each tissue | 2.95e-05 | 184 | 15 | 3 | 10607d7d92edcbb92d992900086b90b307421cc3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.00e-05 | 185 | 15 | 3 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.00e-05 | 185 | 15 | 3 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.05e-05 | 186 | 15 | 3 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.05e-05 | 186 | 15 | 3 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | megakaryocytic-Megakaryocyte|World / Lineage and Cell class | 3.05e-05 | 186 | 15 | 3 | acd15a169b6122b28cc99ef34de10701edcfedfe | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.05e-05 | 186 | 15 | 3 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.10e-05 | 187 | 15 | 3 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Tumor_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.10e-05 | 187 | 15 | 3 | 2713f526f86911fbbf6c7a3e69230f2e6bde31c3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-05 | 189 | 15 | 3 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 189 | 15 | 3 | 7c6d586f352d0d44c24079e76272cb3a545441b5 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 189 | 15 | 3 | 2a5fda73d38bdc23cf47e5335ffd4e086e990245 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.20e-05 | 189 | 15 | 3 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 189 | 15 | 3 | 5438baaa3056fec46d59f75f03f27a93601936c1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.25e-05 | 190 | 15 | 3 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.25e-05 | 190 | 15 | 3 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.25e-05 | 190 | 15 | 3 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.25e-05 | 190 | 15 | 3 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.25e-05 | 190 | 15 | 3 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.25e-05 | 190 | 15 | 3 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.25e-05 | 190 | 15 | 3 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 191 | 15 | 3 | 1f660ea2841324d13f63e01f1789e606c2843fc4 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.30e-05 | 191 | 15 | 3 | 47f20686001f945bc31d5a0b974958e4009edb34 | |
| ToppCell | COVID-19_Severe-B_intermediate|World / disease group, cell group and cell class | 3.30e-05 | 191 | 15 | 3 | f226fd69a26124ba98e4544f550b89a08e6a3708 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-05 | 192 | 15 | 3 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.35e-05 | 192 | 15 | 3 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.35e-05 | 192 | 15 | 3 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.35e-05 | 192 | 15 | 3 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-05 | 192 | 15 | 3 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | 3'-Distal_airway-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-05 | 192 | 15 | 3 | 2ec132a1740e865e7cc0f82ffd4772d43f7ac086 | |
| ToppCell | 3'-Distal_airway-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-05 | 192 | 15 | 3 | 3792c53b5d4b759573e1c7bb89ef9b654c9cbfcd | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.35e-05 | 192 | 15 | 3 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | 3'-Distal_airway-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-05 | 192 | 15 | 3 | 64022a47dccd7966777f6741d1c68e298f37ca9d | |
| ToppCell | 3'-Distal_airway-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-05 | 192 | 15 | 3 | f67a88bd039944d3d7a5a4a9f2e053985075155c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-05 | 193 | 15 | 3 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 193 | 15 | 3 | 735a72fac16397edde95e8eefa6f83caeb5ee5df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.40e-05 | 193 | 15 | 3 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-05 | 193 | 15 | 3 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 193 | 15 | 3 | 0ca0439dfdcb2361ca8d1015fb874a5b5c635d31 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 193 | 15 | 3 | d08919db9601941569b9a143dad4d8e6f56a4389 | |
| ToppCell | severe_COVID-19-Platelet|World / disease group, cell group and cell class (v2) | 3.40e-05 | 193 | 15 | 3 | a598a0665652cc365eb08e413a711c929b80fec7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-05 | 193 | 15 | 3 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.40e-05 | 193 | 15 | 3 | a2fb7482e79d6ce5b6b1d9d0c0811d1c58b4d85d | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 193 | 15 | 3 | ff901d2f3d7a511639c1e3b76058896c0d8a8602 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.40e-05 | 193 | 15 | 3 | 1d724ccb745cfc624119dd6003d53b84b17c94b0 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 194 | 15 | 3 | 20a0439fa02c5f8107612e34c7ab54120b9b8573 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.46e-05 | 194 | 15 | 3 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.46e-05 | 194 | 15 | 3 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 3.46e-05 | 194 | 15 | 3 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 194 | 15 | 3 | 415801a3dfacf05f2b603fb424df3d045190a812 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 194 | 15 | 3 | 48063c9fe3e12aeff0707acada1baa2f8621f093 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.46e-05 | 194 | 15 | 3 | f772a9f9ef8635aeaeb8b022dbb94e9672b36ead | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.46e-05 | 194 | 15 | 3 | 5d2b3ed5374e2ab10c1c7eb3a03139fc95036a48 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 194 | 15 | 3 | c422aeddb4e949a22f731da675bdf91dee86ba61 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.46e-05 | 194 | 15 | 3 | 3b73f2d305a7566f7ab567e5f18c82cd3d80e32c | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 194 | 15 | 3 | 4f31d2cf7eb37b45fefc4da5b41aac0bfdd847b3 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.46e-05 | 194 | 15 | 3 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 194 | 15 | 3 | 256cb33ec90328f2704921fb0fe0fd9812e138b0 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 194 | 15 | 3 | 7942bc83c1bdca687795b91aa232824d603f9b09 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 3.56e-05 | 196 | 15 | 3 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-05 | 196 | 15 | 3 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.56e-05 | 196 | 15 | 3 | d4676a6b0d9e417795fc9a6bcb1762d3dd656ca9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-05 | 196 | 15 | 3 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.56e-05 | 196 | 15 | 3 | 3fd5567ea14193181929134c377e8a38fb4f47fd | |
| Drug | Arg-tyr-asp | 2.66e-05 | 12 | 15 | 2 | CID000131136 | |
| Drug | aminyl | 3.29e-05 | 97 | 15 | 3 | CID000123329 | |
| Drug | prolylleucine | 5.48e-05 | 17 | 15 | 2 | CID000444109 | |
| Drug | pp J | 1.63e-04 | 29 | 15 | 2 | CID006323476 | |
| Drug | phenelzine | 2.25e-04 | 34 | 15 | 2 | CID000003675 | |
| Drug | Securinine [5610-40-2]; Down 200; 18.4uM; HL60; HT_HG-U133A | 2.31e-04 | 187 | 15 | 3 | 2729_DN | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 2.38e-04 | 189 | 15 | 3 | 5455_UP | |
| Drug | allylamine | 2.52e-04 | 36 | 15 | 2 | CID000007853 | |
| Drug | Felodipine [72509-76-3]; Up 200; 10.4uM; PC3; HT_HG-U133A | 2.61e-04 | 195 | 15 | 3 | 6695_UP | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.65e-04 | 196 | 15 | 3 | 2270_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; ssMCF7; HG-U133A | 2.65e-04 | 196 | 15 | 3 | 403_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 3605_UP | |
| Drug | Pempidine tartrate [546-48-5]; Up 200; 13uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 3832_UP | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 2802_UP | |
| Drug | Nafcillin sodium salt monohydrate [7177-50-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 4103_UP | |
| Drug | alunite | 3.27e-04 | 41 | 15 | 2 | CID000062667 | |
| Drug | 3',4',5,7-tetrahydroxyflavanone | 4.31e-04 | 47 | 15 | 2 | CID000011095 | |
| Drug | pyridine | 4.73e-04 | 239 | 15 | 3 | CID000001049 | |
| Drug | Rgd Peptide | 4.73e-04 | 239 | 15 | 3 | CID000104802 | |
| Drug | quipazine | 6.11e-04 | 56 | 15 | 2 | CID000005011 | |
| Drug | fenpropathrin | 7.49e-04 | 62 | 15 | 2 | CID000047326 | |
| Drug | nordiazepam | 7.98e-04 | 64 | 15 | 2 | CID000002997 | |
| Drug | lactofen | 1.27e-03 | 81 | 15 | 2 | CID000062276 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 5.84e-06 | 8 | 14 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 2.32e-04 | 261 | 14 | 3 | C0004352 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.30e-03 | 152 | 14 | 2 | DOID:0060041 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GYGTSSYCWLSLEGG | 1061 | O60241 | |
| WDTFSCDCLGTGYTG | 566 | Q9BZ76 | |
| WNTEGSYDCVCSPGY | 86 | Q9UHX3 | |
| DWDSYSCSCDPGYYG | 1811 | Q9HCU4 | |
| HYSEWSQCSRSCGGG | 971 | P59510 | |
| KNWCEEQYSGGCYTT | 386 | P27338 | |
| CTVSGGSISSGGYYW | 41 | P0DP07 | |
| LSYPDWGSGCYQVSC | 541 | Q96KR4 | |
| IGWAYYCTGAGATAA | 166 | Q9Y693 | |
| GDCLCDSDWTGYYCN | 571 | P05106 | |
| NTEGGYTCSCTDGYW | 146 | Q9UBX5 | |
| YTCSCTDGYWLLEGQ | 151 | Q9UBX5 | |
| WDTFSCDCLGTGYTG | 566 | Q96NU0 | |
| ESIYCGGGSSSACVW | 756 | Q9H4L5 | |
| IWGYTCTCSPGYEGS | 106 | P22891 | |
| SWGFDDFSCCLGSYG | 2906 | Q6ZS81 |